Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.) -- Ignore unavailable to you. Want to Upgrade?

To: Bryce Elkins who wrote (2700)	7/23/1999 1:06:00 PM
From: Abuckatatime	Read Replies (1) \| Respond to of 3414

Bryce, Not sure what the driving force is here - rev & eps growth, institutional accumulation, day-traders, buyout speculation, etc. - but it feels good! EPS of $1.10 looks doable in that margins are improving, the product line is expanding, pharmacy services are being added, and e-commerce is around the corner...plus, growth of the diabetic customer base continues to remain consistently strong. Discounting the growth rate (over 30%) for various factors - small cap, heavy dependence on single payer and single product, capitalizing of direct ad costs, and whatever else you want to include that the street doesn't particularly like - and assigning a PE of 20, I see $20 - $22 as a reasonable six month target. May I error in being too conservative! JMHO. Greg